nodes	percent_of_prediction	percent_of_DWPC	metapath
Niclosamide—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0698	0.0817	CbGbCtD
Niclosamide—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0657	0.0768	CbGbCtD
Niclosamide—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0657	0.0768	CbGbCtD
Niclosamide—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0629	0.0736	CbGbCtD
Niclosamide—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0594	0.0695	CbGbCtD
Niclosamide—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0592	0.0692	CbGbCtD
Niclosamide—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0592	0.0692	CbGbCtD
Niclosamide—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0535	0.0626	CbGbCtD
Niclosamide—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0535	0.0626	CbGbCtD
Niclosamide—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0498	0.0582	CbGbCtD
Niclosamide—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0462	0.054	CbGbCtD
Niclosamide—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.045	0.0527	CbGbCtD
Niclosamide—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0448	0.0525	CbGbCtD
Niclosamide—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0406	0.0474	CbGbCtD
Niclosamide—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0406	0.0474	CbGbCtD
Niclosamide—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0389	0.0455	CbGbCtD
Niclosamide—STAT3—endothelium—acquired immunodeficiency syndrome	0.0134	0.149	CbGeAlD
Niclosamide—STAT3—blood plasma—acquired immunodeficiency syndrome	0.0119	0.132	CbGeAlD
Niclosamide—STAT3—retina—acquired immunodeficiency syndrome	0.00651	0.0723	CbGeAlD
Niclosamide—STAT3—skin of body—acquired immunodeficiency syndrome	0.00572	0.0635	CbGeAlD
Niclosamide—STAT3—lymphoid tissue—acquired immunodeficiency syndrome	0.00463	0.0514	CbGeAlD
Niclosamide—STAT3—digestive system—acquired immunodeficiency syndrome	0.00457	0.0508	CbGeAlD
Niclosamide—STAT3—blood—acquired immunodeficiency syndrome	0.00436	0.0484	CbGeAlD
Niclosamide—STAT3—bone marrow—acquired immunodeficiency syndrome	0.00422	0.0468	CbGeAlD
Niclosamide—STAT3—spinal cord—acquired immunodeficiency syndrome	0.0042	0.0466	CbGeAlD
Niclosamide—STAT3—vagina—acquired immunodeficiency syndrome	0.00404	0.0448	CbGeAlD
Niclosamide—STAT3—lung—acquired immunodeficiency syndrome	0.00382	0.0424	CbGeAlD
Niclosamide—STAT3—nervous system—acquired immunodeficiency syndrome	0.00354	0.0393	CbGeAlD
Niclosamide—STAT3—central nervous system—acquired immunodeficiency syndrome	0.0034	0.0378	CbGeAlD
Niclosamide—STAT3—IL12-mediated signaling events—CCL4—acquired immunodeficiency syndrome	0.003	0.0558	CbGpPWpGaD
Niclosamide—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00281	0.0312	CbGeAlD
Niclosamide—STAT3—brain—acquired immunodeficiency syndrome	0.0027	0.03	CbGeAlD
Niclosamide—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00267	0.0296	CbGeAlD
Niclosamide—STAT3—lymph node—acquired immunodeficiency syndrome	0.00261	0.029	CbGeAlD
Niclosamide—STAT3—IL12-mediated signaling events—CCL3—acquired immunodeficiency syndrome	0.00205	0.0381	CbGpPWpGaD
Niclosamide—STAT3—GMCSF-mediated signaling events—CSF2—acquired immunodeficiency syndrome	0.00192	0.0358	CbGpPWpGaD
Niclosamide—STAT3—Interleukin-6 signaling—IL6—acquired immunodeficiency syndrome	0.00158	0.0293	CbGpPWpGaD
Niclosamide—STAT3—IL27-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.00152	0.0282	CbGpPWpGaD
Niclosamide—STAT3—IL-4 Signaling Pathway—IL4—acquired immunodeficiency syndrome	0.0014	0.026	CbGpPWpGaD
Niclosamide—STAT3—IL12 signaling mediated by STAT4—IFNG—acquired immunodeficiency syndrome	0.00135	0.0252	CbGpPWpGaD
Niclosamide—STAT3—IL27-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.00135	0.0251	CbGpPWpGaD
Niclosamide—STAT3—CXCR4-mediated signaling events—CXCL12—acquired immunodeficiency syndrome	0.00133	0.0248	CbGpPWpGaD
Niclosamide—STAT3—CXCR4-mediated signaling events—CXCR4—acquired immunodeficiency syndrome	0.00133	0.0248	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—CD8A—acquired immunodeficiency syndrome	0.00131	0.0243	CbGpPWpGaD
Niclosamide—STAT3—IL12 signaling mediated by STAT4—CD4—acquired immunodeficiency syndrome	0.00131	0.0243	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—IL4—acquired immunodeficiency syndrome	0.00129	0.0239	CbGpPWpGaD
Niclosamide—STAT3—IL12 signaling mediated by STAT4—IL2—acquired immunodeficiency syndrome	0.0012	0.0224	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—CCR5—acquired immunodeficiency syndrome	0.0012	0.0222	CbGpPWpGaD
Niclosamide—STAT3—IL23-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.00114	0.0213	CbGpPWpGaD
Niclosamide—STAT3—IL23-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.0011	0.0205	CbGpPWpGaD
Niclosamide—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.00108	0.012	CbGeAlD
Niclosamide—CYP1A2—blood—acquired immunodeficiency syndrome	0.00103	0.0114	CbGeAlD
Niclosamide—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.00103	0.0114	CbGeAlD
Niclosamide—STAT3—IL23-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.00102	0.0189	CbGpPWpGaD
Niclosamide—STAT3—IFN-gamma pathway—IFNG—acquired immunodeficiency syndrome	0.00101	0.0189	CbGpPWpGaD
Niclosamide—STAT3—IL27-mediated signaling events—TNF—acquired immunodeficiency syndrome	0.000982	0.0183	CbGpPWpGaD
Niclosamide—CYP2C9—blood—acquired immunodeficiency syndrome	0.000978	0.0109	CbGeAlD
Niclosamide—STAT3—IL-5 Signaling Pathway—IL2—acquired immunodeficiency syndrome	0.000955	0.0178	CbGpPWpGaD
Niclosamide—STAT3—IL-2 Signaling Pathway—IL2—acquired immunodeficiency syndrome	0.000918	0.0171	CbGpPWpGaD
Niclosamide—STAT3—Notch-mediated HES/HEY network—CD4—acquired immunodeficiency syndrome	0.000912	0.017	CbGpPWpGaD
Niclosamide—CYP1A2—lung—acquired immunodeficiency syndrome	0.000903	0.01	CbGeAlD
Niclosamide—STAT3—TGF-beta Receptor Signaling—IFNG—acquired immunodeficiency syndrome	0.000845	0.0157	CbGpPWpGaD
Niclosamide—STAT3—IL2-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.000845	0.0157	CbGpPWpGaD
Niclosamide—Diflunisal—ALB—acquired immunodeficiency syndrome	0.000838	0.658	CrCbGaD
Niclosamide—STAT3—Signaling by Interleukins—CSF2—acquired immunodeficiency syndrome	0.000816	0.0152	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Leptin—IL6—acquired immunodeficiency syndrome	0.000792	0.0147	CbGpPWpGaD
Niclosamide—STAT3—IL27-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.000792	0.0147	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—IFNG—acquired immunodeficiency syndrome	0.000777	0.0145	CbGpPWpGaD
Niclosamide—STAT3—IL2-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.000751	0.014	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.00075	0.014	CbGpPWpGaD
Niclosamide—STAT3—IL23-mediated signaling events—TNF—acquired immunodeficiency syndrome	0.00074	0.0138	CbGpPWpGaD
Niclosamide—STAT3—IL12-mediated signaling events—IL2—acquired immunodeficiency syndrome	0.00069	0.0128	CbGpPWpGaD
Niclosamide—STAT3—IL23-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.000597	0.0111	CbGpPWpGaD
Niclosamide—STAT3—CXCR4-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.000573	0.0107	CbGpPWpGaD
Niclosamide—STAT3—TGF-beta Receptor Signaling—TNF—acquired immunodeficiency syndrome	0.000547	0.0102	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000533	0.00991	CbGpPWpGaD
Niclosamide—STAT3—IL-6 signaling pathway—IL6—acquired immunodeficiency syndrome	0.00053	0.00985	CbGpPWpGaD
Niclosamide—STAT3—TSLP Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.000493	0.00918	CbGpPWpGaD
Niclosamide—STAT3—IL6-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.000493	0.00918	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IFNA1—acquired immunodeficiency syndrome	0.000487	0.00906	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by HDAC Class I—TNF—acquired immunodeficiency syndrome	0.000445	0.00827	CbGpPWpGaD
Niclosamide—Clonazepam—ALB—acquired immunodeficiency syndrome	0.000435	0.342	CrCbGaD
Niclosamide—STAT3—Signaling by Interleukins—IL2—acquired immunodeficiency syndrome	0.000431	0.00802	CbGpPWpGaD
Niclosamide—STAT3—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	0.000384	0.00715	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—CSF2—acquired immunodeficiency syndrome	0.000381	0.00709	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-B—acquired immunodeficiency syndrome	0.000367	0.00682	CbGpPWpGaD
Niclosamide—STAT3—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000343	0.00638	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000337	0.00627	CbGpPWpGaD
Niclosamide—STAT3—Disease—CCNT1—acquired immunodeficiency syndrome	0.000292	0.00543	CbGpPWpGaD
Niclosamide—STAT3—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000274	0.0051	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—TNF—acquired immunodeficiency syndrome	0.000271	0.00504	CbGpPWpGaD
Niclosamide—STAT3—Senescence-Associated Secretory Phenotype (SASP)—IL6—acquired immunodeficiency syndrome	0.000259	0.00482	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—IL6—acquired immunodeficiency syndrome	0.000254	0.00472	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IFNG—acquired immunodeficiency syndrome	0.000227	0.00421	CbGpPWpGaD
Niclosamide—STAT3—Immune System—MBL2—acquired immunodeficiency syndrome	0.000225	0.00419	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—IL6—acquired immunodeficiency syndrome	0.000219	0.00407	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	0.000205	0.00381	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000204	0.0038	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000204	0.0038	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL2—acquired immunodeficiency syndrome	0.000201	0.00374	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000185	0.00344	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	0.000184	0.00343	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CCR2—acquired immunodeficiency syndrome	0.000177	0.00328	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	0.000171	0.00318	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	0.000167	0.00311	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000167	0.0031	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—IL6—acquired immunodeficiency syndrome	0.000164	0.00305	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000159	0.00296	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD79A—acquired immunodeficiency syndrome	0.000154	0.00287	CbGpPWpGaD
Niclosamide—STAT3—Disease—CXCR4—acquired immunodeficiency syndrome	0.000153	0.00285	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	0.000151	0.00281	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.000148	0.00276	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000139	0.00259	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000126	0.00235	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000126	0.00234	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CSF2—acquired immunodeficiency syndrome	0.000124	0.00231	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD8A—acquired immunodeficiency syndrome	0.000124	0.00231	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—IL6—acquired immunodeficiency syndrome	0.000124	0.00231	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-B—acquired immunodeficiency syndrome	0.00012	0.00223	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000119	0.00222	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL6—acquired immunodeficiency syndrome	0.000118	0.0022	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—IL6—acquired immunodeficiency syndrome	0.000116	0.00216	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000114	0.00212	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	0.000108	0.00201	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	0.000108	0.00201	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000107	0.002	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000107	0.002	CbGpPWpGaD
Niclosamide—STAT3—Disease—CCR5—acquired immunodeficiency syndrome	0.000105	0.00195	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—TNF—acquired immunodeficiency syndrome	9.31e-05	0.00173	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.17e-05	0.00152	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.05e-05	0.0015	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—IL6—acquired immunodeficiency syndrome	7.51e-05	0.0014	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IFNG—acquired immunodeficiency syndrome	7.4e-05	0.00138	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.36e-05	0.00137	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	7.31e-05	0.00136	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD4—acquired immunodeficiency syndrome	7.15e-05	0.00133	CbGpPWpGaD
Niclosamide—STAT3—Disease—CD4—acquired immunodeficiency syndrome	6.6e-05	0.00123	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL2—acquired immunodeficiency syndrome	6.58e-05	0.00122	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	6.24e-05	0.00116	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	6.21e-05	0.00116	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	5.31e-05	0.000987	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.25e-05	0.000791	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL6—acquired immunodeficiency syndrome	3.87e-05	0.000719	CbGpPWpGaD
Niclosamide—STAT3—Disease—IL6—acquired immunodeficiency syndrome	3.57e-05	0.000664	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.86e-05	0.000532	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.5e-05	0.000465	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.44e-05	0.000455	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	1.27e-05	0.000237	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	1.09e-05	0.000202	CbGpPWpGaD
